We also observed good correlation between CD8+ T cells and NK cells in cancers where immunotherapy has not been tested yet, such as testicular germ cell cancer (TGCT), KIRP, and lung squamous cell carcinoma (LUSC) and speculate that a subset of tumor samples from these cancers may be sensitive to checkpoint inhibitor treatment. Here, CD8A is linked to neoplasm.